---
title: Merck KGaA vs Yongtai Technology
slug_a: merck-kgaa
slug_b: yongtaitech
site: cdmo
review_signal_gate: closed
canonical_path: /compare/merck-kgaa/yongtaitech
---

# Merck KGaA vs Yongtai Technology

Side-by-side profile data from each company listing on this directory.

## Merck KGaA

- Profile: [/companies/merck-kgaa](/companies/merck-kgaa)

Merck KGaA — Recent coverage reports that Merck KGaA plans to sell its life science CDMO business to Lonza. The same coverage describes a new €300 million bioprocessing center in Daejeon, South Korea.

Services: 0. Modalities: 0. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in locations (1).

### Services

- Data not yet provided.

### Modalities

- Data not yet provided.

### Development capabilities

- Data not yet provided.

### Manufacturing capabilities

- Data not yet provided.

## Yongtai Technology

- Profile: [/companies/yongtaitech](/companies/yongtaitech)

Yongtai Technology — Yongtai Technology is a chemical manufacturing and contract services provider based in Linhai, Zhejiang, operating pharmaceutical, agrochemical, and materials business divisions with capabilities in API synthesis and chemical manufacturing.

Services: 2. Modalities: 0. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (2).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing

### Modalities

- Data not yet provided.

### Development capabilities

- Data not yet provided.

### Manufacturing capabilities

- Data not yet provided.